Low values of 5-hydroxymethylcytosine (5hmC), the "sixth base," are associated with anaplasia in human brain tumors.

MLA

Kraus, Theo F. J., et al. “Low Values of 5-Hydroxymethylcytosine (5hmC), the ‘Sixth Base,’ Are Associated with Anaplasia in Human Brain Tumors.” International Journal of Cancer, vol. 131, no. 7, Oct. 2012, pp. 1577–90. EBSCOhost, https://doi.org/10.1002/ijc.27429.

APA

Kraus, T. F. J., Globisch, D., Wagner, M., Eigenbrod, S., Widmann, D., Münzel, M., Müller, M., Pfaffeneder, T., Hackner, B., Feiden, W., Schüller, U., Carell, T., & Kretzschmar, H. A. (2012). Low values of 5-hydroxymethylcytosine (5hmC), the “sixth base,” are associated with anaplasia in human brain tumors. International Journal of Cancer, 131(7), 1577–1590. https://doi.org/10.1002/ijc.27429

Chicago

Kraus, Theo F J, Daniel Globisch, Mirko Wagner, Sabina Eigenbrod, David Widmann, Martin Münzel, Markus Müller, et al. 2012. “Low Values of 5-Hydroxymethylcytosine (5hmC), the ‘Sixth Base,’ Are Associated with Anaplasia in Human Brain Tumors.” International Journal of Cancer 131 (7): 1577–90. doi:10.1002/ijc.27429.